{"id":2710,"date":"2023-01-16T14:58:54","date_gmt":"2023-01-16T19:58:54","guid":{"rendered":"https:\/\/fifarma.org\/?post_type=publicaciones&#038;p=2710"},"modified":"2025-06-18T17:46:05","modified_gmt":"2025-06-18T22:46:05","slug":"unlocking-the-potential-of-advanced-therapies-for-patients-in-latin-america","status":"publish","type":"publicaciones","link":"https:\/\/fifarma.org\/en\/publications\/unlocking-the-potential-of-advanced-therapies-for-patients-in-latin-america\/","title":{"rendered":"Unlocking the Potential of Advanced Therapies for Patients in Latin America"},"content":{"rendered":"\n<p>Advanced Therapies have the potential to address major unmet health needs, changing the courses of diseases by alleviating the underlying causes and even potentially curing certain conditions. However, the benefits of these products bring with them novel regulatory challenges. <\/p>\n\n\n\n<div class=\"wp-block-file\"><a id=\"wp-block-file--media-ded8673d-66ec-42f1-8a79-f060ad32ed0a\" href=\"https:\/\/fifarma.org\/wp-content\/uploads\/2023\/01\/Unlocking-the-Potential-of-Advanced-Therapies-for-Patients-in-Latin-America.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Preview<\/a><\/div>\n\n\n<div class=\"taxonomy-idioma wp-block-post-terms\"><a href=\"https:\/\/fifarma.org\/en\/language\/english\/\" rel=\"tag\">English<\/a><\/div>\n\n<div class=\"taxonomy-ano wp-block-post-terms\"><a href=\"https:\/\/fifarma.org\/en\/year\/2020\/\" rel=\"tag\">2020<\/a><\/div>\n\n<div class=\"taxonomy-etiquetas-publicacion wp-block-post-terms\"><a href=\"https:\/\/fifarma.org\/en\/publications-tags\/regulatory-affairs\/\" rel=\"tag\">Asuntos regulatorios<\/a><\/div>\n    <div class=\"xs_social_share_widget xs_share_url after_content \t\tmain_content  wslu-style-1 wslu-share-box-shaped wslu-fill-colored wslu-none wslu-share-horizontal wslu-theme-font-no wslu-main_content\">\n\n\t\t\n        <ul>\n\t\t\t        <\/ul>\n    <\/div> \n","protected":false},"author":24,"parent":0,"template":"","ano":[34],"idioma":[45],"etiquetas-publicacion":[39],"categoria-publicacion":[36],"class_list":["post-2710","publicaciones","type-publicaciones","status-publish","hentry","ano-34","idioma-english","etiquetas-publicacion-asuntos-regulatorios","categoria-publicacion-position-paper"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.7 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Unlocking the Potential of Advanced Therapies for Patients in Latin America - FIFARMA<\/title>\n<meta name=\"description\" content=\"Advanced Therapies have the potential to address major unmet health needs, changing the courses of diseases by alleviating the underlying causes and even potentially curing certain conditions. However, the benefits of these products bring with them novel regulatory challenges.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fifarma.org\/en\/publications\/unlocking-the-potential-of-advanced-therapies-for-patients-in-latin-america\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Unlocking the Potential of Advanced Therapies for Patients in Latin America\" \/>\n<meta property=\"og:description\" content=\"Advanced Therapies have the potential to address major unmet health needs, changing the courses of diseases by alleviating the underlying causes and even potentially curing certain conditions. However, the benefits of these products bring with them novel regulatory challenges.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fifarma.org\/en\/publications\/unlocking-the-potential-of-advanced-therapies-for-patients-in-latin-america\/\" \/>\n<meta property=\"og:site_name\" content=\"FIFARMA\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-18T22:46:05+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/unlocking-the-potential-of-advanced-therapies-for-patients-in-latin-america\\\/\",\"url\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/unlocking-the-potential-of-advanced-therapies-for-patients-in-latin-america\\\/\",\"name\":\"Unlocking the Potential of Advanced Therapies for Patients in Latin America - FIFARMA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#website\"},\"datePublished\":\"2023-01-16T19:58:54+00:00\",\"dateModified\":\"2025-06-18T22:46:05+00:00\",\"description\":\"Advanced Therapies have the potential to address major unmet health needs, changing the courses of diseases by alleviating the underlying causes and even potentially curing certain conditions. However, the benefits of these products bring with them novel regulatory challenges.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/unlocking-the-potential-of-advanced-therapies-for-patients-in-latin-america\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/unlocking-the-potential-of-advanced-therapies-for-patients-in-latin-america\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/unlocking-the-potential-of-advanced-therapies-for-patients-in-latin-america\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/fifarma.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Publicaciones\",\"item\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Unlocking the Potential of Advanced Therapies for Patients in Latin America\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#website\",\"url\":\"https:\\\/\\\/fifarma.org\\\/\",\"name\":\"FIFARMA\",\"description\":\"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica\",\"publisher\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fifarma.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#organization\",\"name\":\"Fifarma\",\"alternateName\":\"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica\",\"url\":\"https:\\\/\\\/fifarma.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/logo-fifarma.png\",\"contentUrl\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/logo-fifarma.png\",\"width\":195,\"height\":39,\"caption\":\"Fifarma\"},\"image\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Unlocking the Potential of Advanced Therapies for Patients in Latin America - FIFARMA","description":"Advanced Therapies have the potential to address major unmet health needs, changing the courses of diseases by alleviating the underlying causes and even potentially curing certain conditions. However, the benefits of these products bring with them novel regulatory challenges.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fifarma.org\/en\/publications\/unlocking-the-potential-of-advanced-therapies-for-patients-in-latin-america\/","og_locale":"en_US","og_type":"article","og_title":"Unlocking the Potential of Advanced Therapies for Patients in Latin America","og_description":"Advanced Therapies have the potential to address major unmet health needs, changing the courses of diseases by alleviating the underlying causes and even potentially curing certain conditions. However, the benefits of these products bring with them novel regulatory challenges.","og_url":"https:\/\/fifarma.org\/en\/publications\/unlocking-the-potential-of-advanced-therapies-for-patients-in-latin-america\/","og_site_name":"FIFARMA","article_modified_time":"2025-06-18T22:46:05+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/fifarma.org\/publicaciones\/unlocking-the-potential-of-advanced-therapies-for-patients-in-latin-america\/","url":"https:\/\/fifarma.org\/publicaciones\/unlocking-the-potential-of-advanced-therapies-for-patients-in-latin-america\/","name":"Unlocking the Potential of Advanced Therapies for Patients in Latin America - FIFARMA","isPartOf":{"@id":"https:\/\/fifarma.org\/#website"},"datePublished":"2023-01-16T19:58:54+00:00","dateModified":"2025-06-18T22:46:05+00:00","description":"Advanced Therapies have the potential to address major unmet health needs, changing the courses of diseases by alleviating the underlying causes and even potentially curing certain conditions. However, the benefits of these products bring with them novel regulatory challenges.","breadcrumb":{"@id":"https:\/\/fifarma.org\/publicaciones\/unlocking-the-potential-of-advanced-therapies-for-patients-in-latin-america\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fifarma.org\/publicaciones\/unlocking-the-potential-of-advanced-therapies-for-patients-in-latin-america\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fifarma.org\/publicaciones\/unlocking-the-potential-of-advanced-therapies-for-patients-in-latin-america\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/fifarma.org\/"},{"@type":"ListItem","position":2,"name":"Publicaciones","item":"https:\/\/fifarma.org\/publicaciones\/"},{"@type":"ListItem","position":3,"name":"Unlocking the Potential of Advanced Therapies for Patients in Latin America"}]},{"@type":"WebSite","@id":"https:\/\/fifarma.org\/#website","url":"https:\/\/fifarma.org\/","name":"FIFARMA","description":"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica","publisher":{"@id":"https:\/\/fifarma.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fifarma.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/fifarma.org\/#organization","name":"Fifarma","alternateName":"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica","url":"https:\/\/fifarma.org\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fifarma.org\/#\/schema\/logo\/image\/","url":"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/logo-fifarma.png","contentUrl":"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/logo-fifarma.png","width":195,"height":39,"caption":"Fifarma"},"image":{"@id":"https:\/\/fifarma.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/publicaciones\/2710","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/publicaciones"}],"about":[{"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/types\/publicaciones"}],"author":[{"embeddable":true,"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/users\/24"}],"wp:attachment":[{"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/media?parent=2710"}],"wp:term":[{"taxonomy":"ano","embeddable":true,"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/ano?post=2710"},{"taxonomy":"idioma","embeddable":true,"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/idioma?post=2710"},{"taxonomy":"etiquetas-publicacion","embeddable":true,"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/etiquetas-publicacion?post=2710"},{"taxonomy":"categoria-publicacion","embeddable":true,"href":"https:\/\/fifarma.org\/en\/wp-json\/wp\/v2\/categoria-publicacion?post=2710"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}